| Application no. and date | 10704068.5 (espacenet) (Federated) (European Patent Register), 20100209 | | Patent/reg. no. and date | DK/EP 2396340, 20131218 | | Publication date | 20111221 | | Priority no. and date | US 151248 P, 20090210 | | EP pub. no. and date |
EP 2396340 20111221 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | NGC/AP/148542 | | Inventor | KIM, Choung, U., 1750 Elizabeth Street
San Carlos
CA 94070, US,
BUTLER, Thomas, 601 Baltic Circle 605
Redwood City
CA 94065, US,
CHO, Aesop, 1656 Notre Dame Drive
Mountain View
CA 94040, US,
XU, Jie, 812 Rigel Lane
Foster City
CA 94404, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/7064 (2006.01) , A61P 31/14 (2006.01) , C07H 19/24 (2006.01) | | Title | Carbanucleosidanaloge til antiviral behandling | | Int. application no. | US2010023586 | | Int. publication no. | WO2010093608 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
